Karah Herdman Parschauer - Net Worth and Insider Trading

Over the past 18 months, Karah Herdman Parschauer made 3 insider transaction in Ultragenyx Pharmaceutical Inc (RARE) with a net sale of 17,940. Other recent insider transactions involving Ultragenyx Pharmaceutical Inc (RARE) include a net sale of 147,853 shares made by Emil D Kakkis , a net sale of 4,391 shares made by Sanders Corazon (corsee) D. , and a net sale of 3,565 shares made by Theodore Alan Huizenga .

In summary, during the past 3 months, insiders sold 40,091 shares of Ultragenyx Pharmaceutical Inc (RARE) in total and bought 0 shares, with a net sale of 40,091 shares. During the past 18 months, 257,334 shares of Ultragenyx Pharmaceutical Inc (RARE) were sold and 0 shares were bought by its insiders, resulting in a net sale of 257,334 shares.

Ultragenyx Pharmaceutical Inc (RARE)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Karah Herdman Parschauer made no insider transaction in Arcturus Therapeutics Holdings Inc (ARCT). Other recent insider transactions involving Arcturus Therapeutics Holdings Inc (ARCT) include a net sale of 132,114 shares made by Pad Chivukula , a net sale of 13,936 shares made by Keith C Kummerfeld , and a net sale of 50,000 shares made by Andy Sassine .

In summary, during the past 3 months, insiders sold 0 shares of Arcturus Therapeutics Holdings Inc (ARCT) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 196,050 shares of Arcturus Therapeutics Holdings Inc (ARCT) were sold and 0 shares were bought by its insiders, resulting in a net sale of 196,050 shares.

Arcturus Therapeutics Holdings Inc (ARCT)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Karah Herdman Parschauer made 1 insider transaction in Evolus Inc (EOLS) with a net sale of 11,931. Other recent insider transactions involving Evolus Inc (EOLS) include a net sale of 695,417 shares made by David Moatazedi , a net sale of 18,581 shares made by Sandra Beaver , and a net sale of 35,076 shares made by Rui Avelar .

In summary, during the past 3 months, insiders sold 8,907 shares of Evolus Inc (EOLS) in total and bought 0 shares, with a net sale of 8,907 shares. During the past 18 months, 2,503,160 shares of Evolus Inc (EOLS) were sold and 174,967 shares were bought by its insiders, resulting in a net sale of 2,328,193 shares.

Evolus Inc (EOLS)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Anebulo Pharmaceuticals Inc (ANEB) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Anebulo Pharmaceuticals Inc (ANEB) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Anebulo Pharmaceuticals Inc (ANEB)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Karah Herdman Parschauer made no insider transaction in Tenaya Therapeutics Inc (TNYA). Other recent insider transactions involving Tenaya Therapeutics Inc (TNYA) include a net sale of 25,800 shares made by Timothy Hoey , a net sale of 21,669 shares made by Faraz Ali , and a net sale of 19,491 shares made by Whittemore Tingley .

In summary, during the past 3 months, insiders sold 19,539 shares of Tenaya Therapeutics Inc (TNYA) in total and bought 0 shares, with a net sale of 19,539 shares. During the past 18 months, 78,976 shares of Tenaya Therapeutics Inc (TNYA) were sold and 4,444,444 shares were bought by its insiders, resulting in a net purchase of 4,365,468 shares.

Tenaya Therapeutics Inc (TNYA)'s detailed insider trading history can be found in Insider Trading Tracker table.